CTOs on the Move

Charles River Laboratories

www.criver.com

 
At Charles River, we are passionate about our role in improving the quality of people`s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.criver.com
  • 251 Ballardvale Street
    Wilmington, MA USA 01887
  • Phone: 781.222.6000

Executives

Name Title Contact Details
Arthur Hubbs
Corporate Senior Vice President of Information Technology and Chief Information Officer Profile
Chris Kaczkowski
Sr. Director, Information Security Engineering, Architecture, Threat Intel, and Security Awareness Profile
Matt Dwyer
Director of Information Technology, Sites and Services Profile

Funding

Charles River Laboratories raised $1B on 03/23/2021

Similar Companies

NephroGenex

NephroGenex is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aulos Bioscience

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

AVI BioPharma

AVI BioPharma, Inc. is a Bothell, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Minute Molecular Diagnostics

Minute Molecular Diagnostics was founded in 2017 as a spinout of the Northwestern University Center for Innovation in Global Health Technology (CIGHT). Comprised of a strong management team with extensive diagnostic industry experience, the company has raised $8 million in funding from the NIH and Diagnostic Industry Executives.

Codexis

Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover and develop novel, high performance enzymes and novel biotherapeutics. Codexis enzymes have applications in the sustainable manufacturing of pharmaceuticals, food, and industrial products; in the creation of the next generation of life science tools; and as gene therapy and biologic therapeutics. The Company`s unique performance enzymes drive improvements such as: reduced energy usage, waste generation and capital requirements; higher yields; higher fidelity diagnostics; and more efficacious therapeutics. Codexis enzymes enable the promise of synthetic biology to improve the health of people and the planet.